Myeloma Patients Europe (MPE) and Amgen are launching a survey for European myeloma patients to understand their information needs and would be very grateful if you would take the time to complete the anonymous survey.
The results of the survey will provide valuable insight into the needs of patients and will be used to inform the information provision strategies of a wide range of stakeholders, including pharmaceutical companies and patient groups. MPE, and its members, will also utilise the results of the survey to inform their advocacy and campaigning strategies which aim to improve the experience of patients across Europe.
To access the survey please click on this link: – https://www.medicalradar.com/ims/ws/benchmark.php?id=133&code=ws5ce7e5815a65f1.06979506